Table 3.
Clinical outcomes.
| Patient outcomes | 2-day
group n = 155 |
7-day
group n = 155 |
p-value | OR (95% CI) |
|---|---|---|---|---|
| Primary outcome, n (%) | ||||
| Cure rate | 123/155 (79.3) | 115/155 (74.2) | 0.28 | 1.3 (0.78–2.2) |
| Secondary outcomes | ||||
| Need for additional antibiotics, n (%) | 5 (3.2) | 3 (1.9) | 0.43 | 0.59 (0.13–2.5) |
| ICU Admissions, n (%) | 8 (5.1) | 5 (3.2) | 0.65 | 0.55 (0.13–2.5) |
| Exacerbation-free interval days; median (IQR) |
121 (99–149) | 110 (89–132) | 0.73 | 1 (0.99–1.003) |
| One-year re-exacerbation rate, n (%) | 54 (34.8) | 45 (29) | 0.19 | 0.71 (0.42–1.19) |
| Death rate, n (%) | 8 (5.2) | 11 (7.1) | 0.26 | 0.51 (0.54–3.59) |
IQR, interquartile range; OR, odds ratio.